MX9305076A - Di- o triazindionas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen. - Google Patents
Di- o triazindionas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.Info
- Publication number
- MX9305076A MX9305076A MX9305076A MX9305076A MX9305076A MX 9305076 A MX9305076 A MX 9305076A MX 9305076 A MX9305076 A MX 9305076A MX 9305076 A MX9305076 A MX 9305076A MX 9305076 A MX9305076 A MX 9305076A
- Authority
- MX
- Mexico
- Prior art keywords
- triazindionas
- procedure
- contain
- preparation
- pharmaceutical compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000005862 Angiotensin II Human genes 0.000 abstract 1
- 101800000733 Angiotensin-2 Proteins 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 206010020571 Hyperaldosteronism Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 abstract 1
- 229950006323 angiotensin ii Drugs 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/08—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
- C07D251/20—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with no nitrogen atoms directly attached to a ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4227773A DE4227773A1 (de) | 1992-08-23 | 1992-08-23 | Di- bzw. Triazindione |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9305076A true MX9305076A (es) | 1994-04-29 |
Family
ID=6466102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9305076A MX9305076A (es) | 1992-08-23 | 1993-08-20 | Di- o triazindionas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0589201A1 (en:Method) |
| JP (1) | JPH06184118A (en:Method) |
| KR (1) | KR940003941A (en:Method) |
| CN (1) | CN1086214A (en:Method) |
| AU (1) | AU4469193A (en:Method) |
| CA (1) | CA2104501A1 (en:Method) |
| CZ (1) | CZ166793A3 (en:Method) |
| DE (1) | DE4227773A1 (en:Method) |
| HU (1) | HUT70201A (en:Method) |
| MX (1) | MX9305076A (en:Method) |
| NO (1) | NO932967L (en:Method) |
| PL (1) | PL300165A1 (en:Method) |
| SK (1) | SK88493A3 (en:Method) |
| TW (1) | TW242620B (en:Method) |
| ZA (1) | ZA936135B (en:Method) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0407342A3 (en) * | 1989-07-06 | 1991-07-10 | Ciba-Geigy Ag | Pyrimidine derivatives |
| US5100897A (en) * | 1989-08-28 | 1992-03-31 | Merck & Co., Inc. | Substituted pyrimidinones as angiotensin ii antagonists |
| US5162326A (en) * | 1990-02-15 | 1992-11-10 | Takeda Chemical Industries, Ltd. | Pyrimidinedione derivatives, their production and use |
-
1992
- 1992-08-23 DE DE4227773A patent/DE4227773A1/de not_active Withdrawn
-
1993
- 1993-08-13 CZ CZ931667A patent/CZ166793A3/cs unknown
- 1993-08-16 EP EP93113069A patent/EP0589201A1/de not_active Withdrawn
- 1993-08-16 SK SK884-93A patent/SK88493A3/sk unknown
- 1993-08-17 AU AU44691/93A patent/AU4469193A/en not_active Abandoned
- 1993-08-18 JP JP5204239A patent/JPH06184118A/ja active Pending
- 1993-08-19 HU HU9302380A patent/HUT70201A/hu unknown
- 1993-08-20 NO NO932967A patent/NO932967L/no unknown
- 1993-08-20 CA CA002104501A patent/CA2104501A1/en not_active Abandoned
- 1993-08-20 MX MX9305076A patent/MX9305076A/es unknown
- 1993-08-20 ZA ZA936135A patent/ZA936135B/xx unknown
- 1993-08-20 PL PL93300165A patent/PL300165A1/xx unknown
- 1993-08-21 KR KR1019930016297A patent/KR940003941A/ko not_active Withdrawn
- 1993-08-21 CN CN93116449A patent/CN1086214A/zh active Pending
- 1993-08-21 TW TW082106753A patent/TW242620B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| NO932967D0 (no) | 1993-08-20 |
| SK88493A3 (en) | 1994-06-08 |
| CA2104501A1 (en) | 1994-02-24 |
| DE4227773A1 (de) | 1994-02-24 |
| TW242620B (en:Method) | 1995-03-11 |
| ZA936135B (en) | 1994-03-17 |
| CN1086214A (zh) | 1994-05-04 |
| CZ166793A3 (en) | 1994-03-16 |
| PL300165A1 (en) | 1994-03-07 |
| AU4469193A (en) | 1994-02-24 |
| EP0589201A1 (de) | 1994-03-30 |
| JPH06184118A (ja) | 1994-07-05 |
| KR940003941A (ko) | 1994-03-14 |
| HUT70201A (en) | 1995-09-28 |
| NO932967L (no) | 1994-02-24 |
| HU9302380D0 (en) | 1993-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9303469A (es) | Derivados de benzimidazol, procedimiento para su preparacion, composicion farmaceutica que los contiene y procedimiento para preparar de la misma. | |
| MX9303597A (es) | Derivados de imidazopirinas, procedimiento para su preparacion preparaciones farmaceuticas que los contienen. | |
| MX9307940A (es) | Nuevos derivados de la imidazopiridina, proceso para su preparacion y formulaciones farmaceuticas que los incluyen | |
| AR008630A1 (es) | Indol-3-glioxilamidas n-sustituidas con efecto antiasmatico, antialergico e inmunosupresor/inmunomodulador, procedimientos para su preparacion, suutilizacion farmaceutica y las composiciones farmaceuticas que las contienen. | |
| MX9201317A (es) | Nuevos derivados de imidazo pirina, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| MX9704777A (es) | Compuestos espiro tetraciclicos, procedimiento para su preparacion y composiciones que los contienen. | |
| ES2122043T3 (es) | Nuevos derivados sustituidos del pirazol, procedimientos para su preparacion y su empleo como herbicidas. | |
| ES2058185T3 (es) | Derivados de camptotecina y procedimiento para su preparacion. | |
| PA8442201A1 (es) | Derivados de 6-fenilpiridil-2-amina | |
| ES2059207T3 (es) | Procedimiento para la preparacion de derivados del taxano, nuevos derivados obtenidos y composiciones farmaceuticas que les contienen. | |
| ECSP034924A (es) | Derivados sustituidos del 1-oxa-2,8-daza-espiro[4,5]dec-2-eno | |
| ES2154262T3 (es) | Uso de compuestos macrolidos para enfermedades oculares. | |
| ES2053778T3 (es) | Procedimiento para la obtencion de derivados del tiazol. | |
| UY26332A1 (es) | Nuevos derivados del ácido aminodicarboxílico con propiedades farmacéuticas. | |
| UY28186A1 (es) | N-arilheterociclos sustituidos, procedimientos para su preparación, y su empleo como medicamentos. | |
| ES2119124T3 (es) | Bencimidazoles utiles para el tratamiento de trastornos del sistema nervioso. | |
| AR005703A1 (es) | Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen | |
| SV2004001690A (es) | Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos | |
| ES2097341T3 (es) | Indoles sustituidos como farmacos para el tratamiento del sida. | |
| CL2021003594A1 (es) | Derivados de 3,6-diamino-piridazin-3-ilo, composiciones farmacéuticas que los contienen y sus usos como agentes proapoptóticos. | |
| MXPA04002042A (es) | Compuestos de bencimidazol sustituidos y su uso para el tratamiento del cancer. | |
| PA8680701A1 (es) | Derivados de oxindol | |
| UY28536A1 (es) | Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos. | |
| ES2135429T3 (es) | Derivados de ciclohexano sustituidos para el tratamiento de enfermedades. | |
| UY28356A1 (es) | Derivados de benzimidazol, composiciones que los contienen, preparaciones de los mismos y sus usos |